［英文原著］（アルファベット順）
1. Arase N, Arase H:Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases. J. Biochem. 2015;158(5):367-72.
2. Tanimura K, Jin H, Suenaga T, Morikami S,Arase N, Kishida K, Hirayasu K, Kohyama M, Ebina Y, Yasuda S, Horita T, Takasugi K, Ohmura K, Yamamoto K, Katayama I, Sasazuki T, Lanier LL, Atsumi T, Yamada H, Arase H:β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. Blood.
2015;125(18):2835-44.
3. Hirobe S,Azukizawa H, Hanafusa T, Matsuo K, Quan YS, Kamiyama F, Katayama I, Okada N, Nakagawa S:
Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials. 2015;57:50-8.
4. Baratin M, Foray C, Demaria O, Habbeddine M, Pollet E, Maurizio J, Verthuy C, Davanture S,Azukizawa H, Flores-Langarica A, Dalod M, Lawrence T: Homeostatic NF-κB Signaling in Steady-State Migratory Dendritic Cells Regulates Immune Homeostasis and Tolerance. Immunity. 2015;42(4):627-39.
5. Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K,Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T: Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J. Dermatol. 2015; 42(3):276-82.
6. Inoue-Nishimoto T, Hanafusa T, Igawa K, Azukizawa H, Yokomi A, Yokozeki H, Katayama I: Possible association of anti-tumor necrosis factor-αantibody therapy with the development of scleroderma-like changes with lichen planus.Eur J Dermatol. 2015;25(5):513-5.
7. Aihara M, Kano Y, Fujita H, Kambara T, Matsukura S,Katayama I, Azukizawa H, Miyachi Y, Endo Y, Asada H, Miyagawa F, Morita E, Kaneko S, Abe R, Ochiai T, Sueki H, Watanabe H, Nagao K, Aoyama Y, Sayama K, Hashimoto K, Shiohara T: Efficacy of additional i.v. immunoglobulin to steroid therapy in Stevens-Johnson syndrome and toxic epidermal necrolysis.SJS/TEN Study Group. J Dermatol. 2015;42(8):768-77.
8. Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T,Katayama I, Anbar T, Abdallah M, Benzekri L, Gauthier Y, Harris J, Silva de Castro CC, Pandya A, Goh BK, Lan CC, Oiso N, Al Issa A, Esmat S, Le Poole C, Lee AY, Parsad D, Taieb A, Picardo M, Ezzedine K; Vitiligo Global Issues Consensus Group:Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.Pigment Cell Melanoma Res. 2015;28 (3):363-9.
9. Tokunaga T, Ninomiya T, Osawa Y, Imoto Y, Ito Y, Takabayashi T, Narita N, Kijima A, Murota H,Katayama I, Fujieda S: Factors associated with the development and remission of allergic diseases in an epidemiological survey of high school students in Japan. Am J Rhinol Allergy. 2015;29(2):94-9.
10. Yamanaka K, Murota H, Goto H, Yamamoto S, Katayama I, Taniguchi Y, Mizutani H: Pyoderma gangrenosum and annular erythema associated with Sjögren’s syndrome controlled with minocycline. J Dermatol.
教室年報2015 原著
11. Nishigori C, Aoyama Y, Ito A, Suzuki K, Suzuki T, Tanemura A, Ito M,Katayama I, Oiso N, Kagohashi Y, Sugiura S, Fukai K, Funasaka Y, Yamashita T, Matsunaga K: Guideline for medical prefessionals (i. e.
derfmatologists) for the management of Rhododenol-induced leukoderma. J Dermatol. 2015;42(2):113-28.
12. Marzese DM, Liu M, Huynh JL, Hirose H, Donovan NC, Huynh KT,Kiyohara E, Chong K, Cheng D, Tanaka R, Wang J, Morton DL, Barkhoudarian G, Kelly DF, Hoon DS:Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome. Pigment Cell Melanoma Res. 2015;28(1):82-93.
13. Kiyohara E, Donovan N, Takeshima L, Huang S, Wilmott JS, Scolyer RA, Jones P, Somers EB, O’Shannessy DJ, Hoon DS:Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications. Cancer Microenviron. 2015;8(2):111-8.
14. Lessard L, Liu M, Marzese DM, Wang H, Chong K, Kawas N, Donovan NC,Kiyohara E, Hsu S, Nelson N, Izraely S, Sagi-Assif O, Witz IP, Ma XJ, Luo Y, Hoon DS:The CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype Switching. J Invest Dermatol. 2015;135(10):2464-74.
15. Saeki H, Imafuku S, Abe M, Shintani Y, Onozuka D, Hagihara A, Katoh N,Murota H, Takeuchi S, Sugaya M, Tanioka M, Kaneko S, Masuda K, Hiragun T, Inomata N, Kitami Y, Tsunemi Y, Abe S, Kobayashi M, Morisky DE, Furue M: Poor adherence to medication as assessed by the Morisky Medication Adherence Scale-8 and low satisfaction with treatment in 237 psoriasis patients. J Dermatol. 2015;42(4):367-72.
16. Lee J, Shin Y,Murota H: Oligonol supplementation modulates plasma volume and osmolality and sweating after heat load in humans. J Med Food. 2015;18(5):578-83.
17. Murota H, Takeuchi S, Sugaya M, Tanioka M, Onozuka D, Hagihara A, Saeki H, Imafuku S, Abe M, Shintani Y, Kaneko S, Masuda K, Hiragun T, Inomata N, Kitami Y,Tsunemi Y, Abe S, Kobayashi M, Morisky DE, Furue M, Katoh N:Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation. J Dermatol Sci. 2015;79(3):279-87.
18. Tsunemi Y, Abe S, Kobayashi M, Kitami Y, Onozuka D, Hagihara A, Takeuchi S, Murota H, Sugaya M, Masuda K, Hiragun T, Kaneko S, Saeki H, Shintani Y, Tanioka M, Imafuku S, Abe M, Inomata N, Morisky DE, Furue M, Katoh N: Adherence to oral and topical medication in 445 patients with tinea pedis as assessed by the Morisky Medication Adherence Scale-8. Eur J Dermatol. 2015;25(6):570-7.
19. Nakagawa Y, Gallo RL: Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages.J Immunol. 2015;194(3):1274-84.
20. Nakano-Tahara M, Terao M, Nishioka M, Kitaba S, Murota H, Katayama I: T Helper 2Polarization in Senile Erythroderma with Elevted Levels of TARC and IgE. Dermatology. .2015;230(1):62-9.
21. Nishioka M, Tanemura A, Yang L, Tanaka A, Arase N, Katayama I:Possible involvement of CCR4+CD8+T cells and elevated plasma CCL22 and CCL17 in patients with rhododenol-induced leukoderma.J Dermatol Sci.
2015;77(3):188-90.
22. Tagami-Nagata N, Serada S, Fujimoto M, Tanemura A, Nakatsuka R, Ohkawara T, Murota H, Kishimoto T, Katayama I, Naka T:Suppressor of cytokine signaling-1 (SOCS-1) induces significant preclinical anti-tumor effect in malignant melanoma cells.Exp Dermatol. 2015;24(11):864-71.
教室年報2015 原著
Hermansky-Pudlak syndrome 1 in a Japanese infant. J Dermatol.2015;42(9):906-7.
24. Jin Y, Hayashi M, Fain PR, Suzuki T, Fukai K, Oiso N,Tanemura A, Holcomb CL, Rastrou M, Erlich HA, Spritz RA:Major association of vitiligo with HLA-A*02:01 in Japanese. Pigment Cell Melanoma Res. 2015;28(3):
360-2.
25. Tanemura A, Yang L, Yang F, Nagata Y, Wataya-Kaneda M, Fukai K, Tsuruta D, Ohe R, Yamakawa M, Suzuki T, Katayama I: An immune pathological and ultrastructual skin analysis for rhododenol-induced leukoderma patients. J Dermatol Sci. 2015;77(3):185-8.
26. Namiki T, Yaguchi T, Nakamura K, Valencia JC, Coelho SG, Yin L, Kawaguchi M, Vieira WD, Kaneko Y, Tanemura A, Katayama I, Yokozeki H, Kawakami Y, Hearing VJ:NUAK2amplification coupled with PTEN deficiency promotes melanoma development via CDK activation. Cencer Res. 2015;75(13):2708-15.
27. Tanemura A, Deguchi A, Tanaka A, Kiyohara E, Kishioka A, Katayama I: A rare case of mucinous carcinoma of the skin with multiple organ metastases. Eur J Dermatol. 2015;25(5):483-4.
28. Terao M, Yang L, Matsumura S, Yutani M, Murota H, Katayama I: A vitamin D analog inhibits Th2cytokine-and TGFβ -induced periostin production in fibroblasts: a potential role for vitamin D in skin sclerosis.
Dermatoendocrinol. 2015;7(1):e1010983.
29. Kato A, Yutani M,Terao M, Kimura A, Itoi S, Murota H, Miyoshi E, Katayama I:Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma. Exp Dermatol. 2015;24(8):585-90.
30. Matsumura S, Terao M, Murota H, Katayama I: Th2cytokines enhance TrkA expression, upregulate proliferation, and downregulate differentiation of keratinocytes. J Dermatol Sci. 2015 ;78(3):215-23.
31. Wataya-Kaneda M, Tanaka M, Yang L, Yang F, Tsuruta D, Nakamura A, Matsumoto S, Hamasaki T, Tanemura A, Katayama I:Clinical and Histologic Analysis of the Efficacy of Topical Rapamycin Therapy Against Hypomelanotic Macules in Tuberous Sclerosis Complex. JAMA Dermatol. 2015;151(7):722-30.
32. Okamura K, Abe Y, Fukai K, Tsuruta D, Suga Y, Nakamura M, Funasaka Y, Oka M, Suzuki N, Wataya-Kaneda M, Seishima M, Hozumi Y, Kawaguchi M, Suzuki T:Mutation analyses of patients with dyschromatosis symmetrica hereditaria:Ten novel mutations of the ADAR1 gene. Journal of Dermatological Science. 2015;79(1):
88-90.
33. Ishii R,Wataya-Kaneda M, Canuet L, Nonomura N, Nakai Y, Takeda M: Everolimus improves behavioral defects in a patient with autism associated with tuberous sclerosis: a case report.Neuropsychiatric Electrophysiology.
2015;1:6.
34. Hashimoto N,Yamaoka T, Koguchi-Yoshioka H, Tanaka A, Tanemura A, Azukizawa H, Murota H, Kang J, Nakagawa Y, Shimazu T, Katayama I: Development of Necrotising Fasciitis in a Patient Treated for Rheumatoid Arthritis with Tocilizumab.Acta Derm Venereol. 2015;95(3):370-1.
35. Yamaoka T, Inoue T, Kitaba S, Yokomi A, Azukizawa H, Terao M, Murota H, Higashiyama M, Katayama I:
Psoriatic Arthritis Complicating Systemic Sclerosis: Possible Involvement of M2Macrophages. Ann Dermatol.
2015;27(5):631-2.
教室年報2015 原著
with internal carotid artery-posterior communicating artery aneurysm. J Dermatol. 2015;42(3):315-7.
37. Yang L, Yang F, Wataya-Kaneda M, Tanemura A, Tsuruta D, Katayama I:4-(4-hydroroxyphenyl)-2-butanol (rhododendrol) activates the autophagy-lysosome pathway in melanocytes: insights into the mechanisms of rhododendrol-induced leukoderma. J Dermatol Sci. 2015;77(3):182-5.
38. Yang L, Fujimoto M, Murota H, Serada S, Fujimoto M, Honda H, Yamada K, Suzuki K, Nishikawa A, Hosono Y, Yoneda Y, Takehara K, Imura Y, Mimori T, Takeuchi T, Katayama I, Naka T: Proteomic identification of heterogeneous nuclear ribonucleoprotein K as a novel cold-associated autoantigen in patients with secondary Raynaud’s phenomenon. Rheumatology (Oxford). 2015;54(2):349-58.
［和文原著］（五十音順）
1. 荒瀬規子，宮下恵実子，崎元和子，片山一朗 :bullous mastocytosis. Visual Dermatology 2015;14(1):48-50.
2. 東 典子，小豆澤宏明，吉岡華子，山岡俊文，片山一朗，榎本圭佑 : 血管性浮腫を伴った低補体血症性 蕁麻疹様血管炎症候群の1例．皮膚の科学 2015;14(3):123-9.
3. 加藤健一，早石祥子，近藤由佳里，倉知貴志郎 :Kyrle病．皮膚病診療 2015;37(7):669-72.
4. 神谷智，庄田裕紀子 : 転移性結核性膿瘍．皮膚病診療 2015;37(6): 557-60.
5. 小紫雄貴，小豆澤宏明，小野慧美，吉岡華子，横見明典，片山一朗，中野智香子，岩谷博次，濱野高 行，猪坂善隆 : 腎炎を伴うHenoch-Schonlein紫斑病と結節性多発動脈炎の合併例．皮膚病診療 2015;
37(7):697-700.
6. 田原真由子，室田浩之，片山一朗 : アトピー性皮膚炎に対するエキシマ光線療法の治療効果．皮膚の科 学 2015;14:33-4.
7. 中里良彦（埼玉医科大学 神経内科），佐藤貴浩，朝比奈正人，横関博雄，岩瀬 敏，室田浩之，佐野 健司，藤本智子，宗次太吉，大嶋雄一郎 : 特発性後天性全身性無汗症診療ガイドライン改訂版．自律神 経 2015;52(4):352-9.
教室年報2015 原著